fbpx
Medical Innovation Exchange

Brooklyn hails immunotherapy for achieving 'primary objective'—but fails the primary endpoint

https://www.fiercebiotech.com/biotech/brooklyn-hails-immunotherapy-achieving-primary-objective-just-not-primary-endpoint

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.